(Q44952434)

English

Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

based on heuristic

inferred from title

author name string

Konstas AG

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Kozobolis VP

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Lallos N

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Christodoulakis E

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Stewart JA

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Stewart WC

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1264-1269

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.eye.6701446

0 references

Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

21 January 2018

Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

21 January 2018

Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

21 January 2018

Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

21 January 2018

Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

21 January 2018

The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

21 January 2018

Perspectives in the medical treatment of glaucoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

21 January 2018

Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study. International Clinical Equivalence Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

21 January 2018

Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

21 January 2018

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

21 January 2018

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

21 January 2018

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

21 January 2018

A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

21 January 2018

Comparison of latanoprost, brimonidine and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-masked crossover study comparing the effects of carteolol 1% and 2% on intra-ocular pressure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

7 January 2021

based on heuristic

inferred from DOI database lookup

The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701446

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.EYE.6701446

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

release_qgq3ogqqlrdsthqmj72uut4dtm

1 reference

https://api.fatcat.wiki/v0/release/qgq3ogqqlrdsthqmj72uut4dtm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44952434&oldid=1843835377"